Hlengiwe P Madlala, Landon Myer, Hayli Geffen, Jennifer Jao, Mushi Matjila, Azetta Fisher, Demi Meyer, Lara Dugas, Amy E Mendham, Gregory Petro, Susan Cu-Uvin, Stephen T McGarvey, Julia H Goedecke, Angela M Bengtson
{"title":"南非妇女HIV感染状况和抗逆转录病毒治疗类别的母体人体测量、身体组成和脂肪分布。","authors":"Hlengiwe P Madlala, Landon Myer, Hayli Geffen, Jennifer Jao, Mushi Matjila, Azetta Fisher, Demi Meyer, Lara Dugas, Amy E Mendham, Gregory Petro, Susan Cu-Uvin, Stephen T McGarvey, Julia H Goedecke, Angela M Bengtson","doi":"10.1177/08892229251374692","DOIUrl":null,"url":null,"abstract":"<p><p>Pregnancy affects adiposity, which may be influenced by HIV infection or antiretroviral therapy (ART). The objective of this study was to examine adiposity measures in the perinatal period, by HIV status and ART class. A total of 214 women (113 women with HIV [WWH], 71 initiated ART postconception), enrolled between 24 and 28 weeks of gestation and followed until 6-12 months postpartum, were assessed for longitudinal weight and cross-sectional postpartum anthropometry. A subset of 65 (52 WWH, 42 initiated ART postconception) had cross-sectional adiposity (body composition and fat distribution) measured at 6-12 months postpartum using dual-energy X-ray absorption scan. Multivariable linear and modified Poisson regression, adjusted for maternal age, pre-pregnancy body mass index, socioeconomic status, and postpartum months, examined associations of HIV status and postconception ART (dolutegravir-based [DTG] vs. efavirenz-based [EFV]) with anthropometry and adiposity outcomes. At enrollment, the median age was 30 years (interquartile range, 26-34) and 82% were multiparous. Between pre-pregnancy and postpartum, women gained an average of 2.33 kg (0.90 kg WWH), 30% lost weight (35% WWH), and 48% gained weight (38% WWH). WWH gained weight slower during pregnancy (0.27 vs 0.38 kg/week, <i>p</i> = .03) and were less likely to gain weight postpartum (RR = 0.72 95% CI 0.55, 0.93; <i>p</i> = .01) compared with women without HIV. Postpartum, mean body mass index was 32 kg/m<sup>2</sup> (standard deviation = 7.33) and 58% (53% WWH) of women had obesity. HIV was not associated with cross-sectional measures of postpartum anthropometry and adiposity. Among WWH, compared with EFV-based ART, DTG-based ART was not associated with weight gain during pregnancy or anthropometry and adiposity postpartum. Despite high rates of postpartum weight gain and obesity, no significant differences were observed in anthropometry and adiposity measures by HIV status and postconception ART. Nonetheless, these findings underscore the need for interventions to support healthy weight gain in pregnancy and postpartum weight loss to minimize pregnancy-associated obesity.</p>","PeriodicalId":7544,"journal":{"name":"AIDS research and human retroviruses","volume":" ","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Maternal Anthropometry, Body Composition, and Fat Distribution by HIV Status and Antiretroviral Therapy Class in South African Women.\",\"authors\":\"Hlengiwe P Madlala, Landon Myer, Hayli Geffen, Jennifer Jao, Mushi Matjila, Azetta Fisher, Demi Meyer, Lara Dugas, Amy E Mendham, Gregory Petro, Susan Cu-Uvin, Stephen T McGarvey, Julia H Goedecke, Angela M Bengtson\",\"doi\":\"10.1177/08892229251374692\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Pregnancy affects adiposity, which may be influenced by HIV infection or antiretroviral therapy (ART). The objective of this study was to examine adiposity measures in the perinatal period, by HIV status and ART class. A total of 214 women (113 women with HIV [WWH], 71 initiated ART postconception), enrolled between 24 and 28 weeks of gestation and followed until 6-12 months postpartum, were assessed for longitudinal weight and cross-sectional postpartum anthropometry. A subset of 65 (52 WWH, 42 initiated ART postconception) had cross-sectional adiposity (body composition and fat distribution) measured at 6-12 months postpartum using dual-energy X-ray absorption scan. Multivariable linear and modified Poisson regression, adjusted for maternal age, pre-pregnancy body mass index, socioeconomic status, and postpartum months, examined associations of HIV status and postconception ART (dolutegravir-based [DTG] vs. efavirenz-based [EFV]) with anthropometry and adiposity outcomes. At enrollment, the median age was 30 years (interquartile range, 26-34) and 82% were multiparous. Between pre-pregnancy and postpartum, women gained an average of 2.33 kg (0.90 kg WWH), 30% lost weight (35% WWH), and 48% gained weight (38% WWH). WWH gained weight slower during pregnancy (0.27 vs 0.38 kg/week, <i>p</i> = .03) and were less likely to gain weight postpartum (RR = 0.72 95% CI 0.55, 0.93; <i>p</i> = .01) compared with women without HIV. Postpartum, mean body mass index was 32 kg/m<sup>2</sup> (standard deviation = 7.33) and 58% (53% WWH) of women had obesity. HIV was not associated with cross-sectional measures of postpartum anthropometry and adiposity. Among WWH, compared with EFV-based ART, DTG-based ART was not associated with weight gain during pregnancy or anthropometry and adiposity postpartum. Despite high rates of postpartum weight gain and obesity, no significant differences were observed in anthropometry and adiposity measures by HIV status and postconception ART. Nonetheless, these findings underscore the need for interventions to support healthy weight gain in pregnancy and postpartum weight loss to minimize pregnancy-associated obesity.</p>\",\"PeriodicalId\":7544,\"journal\":{\"name\":\"AIDS research and human retroviruses\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2025-09-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AIDS research and human retroviruses\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/08892229251374692\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS research and human retroviruses","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/08892229251374692","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
怀孕影响肥胖,这可能受到艾滋病毒感染或抗逆转录病毒治疗(ART)的影响。本研究的目的是通过艾滋病毒状况和抗逆转录病毒治疗班级来检查围生期的肥胖措施。共有214名妇女(113名感染艾滋病毒[WWH], 71名在怀孕后开始抗逆转录病毒治疗),在妊娠24至28周期间入组,并随访至产后6-12个月,评估纵向体重和产后横断面人体测量。在产后6-12个月,使用双能x线吸收扫描测量了65例(52例妊娠前妇女,42例妊娠后接受抗逆转录病毒治疗)的横断面肥胖(身体组成和脂肪分布)。多变量线性和修正泊松回归,调整了产妇年龄、孕前体重指数、社会经济地位和产后月份,研究了HIV感染状况和怀孕后抗逆转录病毒治疗(基于dolutegravir [DTG] vs.基于efavirenz [EFV])与人体测量和肥胖结局的关系。入组时,中位年龄为30岁(四分位数范围为26-34岁),82%为多产。在怀孕前和产后,女性平均增加2.33公斤(0.90公斤WWH), 30%的体重减轻(35% WWH), 48%的体重增加(38% WWH)。孕妇在怀孕期间体重增加较慢(0.27 vs 0.38 kg/周,p = .03),产后体重增加的可能性较低(RR = 0.72 95% CI 0.55, 0.93; p = .01)。产后平均体重指数为32 kg/m2(标准差为7.33),58% (53% WWH)的女性出现肥胖。HIV与产后人体测量和肥胖的横断面测量没有关联。在WWH中,与基于efv的ART相比,基于dtg的ART与妊娠期间体重增加、人体测量和产后肥胖无关。尽管产后体重增加和肥胖率很高,但HIV状态和受孕后抗逆转录病毒治疗在人体测量和肥胖测量方面没有观察到显著差异。尽管如此,这些发现强调了干预的必要性,以支持怀孕期间健康的体重增加和产后体重减轻,以尽量减少怀孕相关的肥胖。
Maternal Anthropometry, Body Composition, and Fat Distribution by HIV Status and Antiretroviral Therapy Class in South African Women.
Pregnancy affects adiposity, which may be influenced by HIV infection or antiretroviral therapy (ART). The objective of this study was to examine adiposity measures in the perinatal period, by HIV status and ART class. A total of 214 women (113 women with HIV [WWH], 71 initiated ART postconception), enrolled between 24 and 28 weeks of gestation and followed until 6-12 months postpartum, were assessed for longitudinal weight and cross-sectional postpartum anthropometry. A subset of 65 (52 WWH, 42 initiated ART postconception) had cross-sectional adiposity (body composition and fat distribution) measured at 6-12 months postpartum using dual-energy X-ray absorption scan. Multivariable linear and modified Poisson regression, adjusted for maternal age, pre-pregnancy body mass index, socioeconomic status, and postpartum months, examined associations of HIV status and postconception ART (dolutegravir-based [DTG] vs. efavirenz-based [EFV]) with anthropometry and adiposity outcomes. At enrollment, the median age was 30 years (interquartile range, 26-34) and 82% were multiparous. Between pre-pregnancy and postpartum, women gained an average of 2.33 kg (0.90 kg WWH), 30% lost weight (35% WWH), and 48% gained weight (38% WWH). WWH gained weight slower during pregnancy (0.27 vs 0.38 kg/week, p = .03) and were less likely to gain weight postpartum (RR = 0.72 95% CI 0.55, 0.93; p = .01) compared with women without HIV. Postpartum, mean body mass index was 32 kg/m2 (standard deviation = 7.33) and 58% (53% WWH) of women had obesity. HIV was not associated with cross-sectional measures of postpartum anthropometry and adiposity. Among WWH, compared with EFV-based ART, DTG-based ART was not associated with weight gain during pregnancy or anthropometry and adiposity postpartum. Despite high rates of postpartum weight gain and obesity, no significant differences were observed in anthropometry and adiposity measures by HIV status and postconception ART. Nonetheless, these findings underscore the need for interventions to support healthy weight gain in pregnancy and postpartum weight loss to minimize pregnancy-associated obesity.
期刊介绍:
AIDS Research and Human Retroviruses was the very first AIDS publication in the field over 30 years ago, and today it is still the critical resource advancing research in retroviruses, including AIDS. The Journal provides the broadest coverage from molecular biology to clinical studies and outcomes research, focusing on developments in prevention science, novel therapeutics, and immune-restorative approaches. Cutting-edge papers on the latest progress and research advances through clinical trials and examination of targeted antiretroviral agents lead to improvements in translational medicine for optimal treatment outcomes.
AIDS Research and Human Retroviruses coverage includes:
HIV cure research
HIV prevention science
- Vaccine research
- Systemic and Topical PreP
Molecular and cell biology of HIV and SIV
Developments in HIV pathogenesis and comorbidities
Molecular biology, immunology, and epidemiology of HTLV
Pharmacology of HIV therapy
Social and behavioral science
Rapid publication of emerging sequence information.